Post-approval studies (Phase 4)Study completedNCT02215863
What this trial is testing
Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years
Who this might be right for
InfluenzaStreptococcus Pneumoniae
Korea University Guro Hospital 1,195